Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

HYPERION THERAPEUTICS INC (HPTX)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsMar-31-15Dec-31-14Sep-30-14Jun-30-14Mar-31-14Dec-31-13Sep-30-13Jun-30-13
   10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q
Cash flows from operating activities          
Net income  7.2-6.3-32.118.71.3 0.116.0
   
Adjustments to reconcile net income to net cash provided by operating activities          
Depreciation and amortization  0.1 0.10.20.1 0.00.1
Loss on disposal of fixed asset  0.0       
Amortization of debt discount  0.1 0.30.30.1 0.10.3
Stock-based compensation expense  2.4 2.33.21.4 1.31.8
Amortization of intangible asset  0.9 1.42.01.0 1.00.3
Change in acquisition related contingency (Note 10)  -4.1       
Amortization of discount on available-for-sale investments  0.1 0.10.20.1   
Unrealized loss on foreign currency remeasurement adjustments  0.0       
Excess tax benefit from stock-based compensation  -0.1-0.10.00.00.0   
   
Changes in assets and liabilities          
Accounts receivable  -6.7-10.52.6-15.02.1-4.4-5.0-1.7
Inventories  -0.9-1.4-1.10.50.7 0.6-1.1
Prepaid expenses and other assets  -0.8-1.7-0.70.50.3-0.8-0.60.3
Accounts payable  4.8-1.90.80.30.7 -0.3-0.1
Deferred revenue  0.0 0.2 0.2   
Accrued liabilities and other  7.4 -6.114.6-0.4 2.72.1
Deferred rent  0.0 0.00.30.2   
    Net cash provided by operating activities  5.6 -0.423.57.0-1.20.2-13.0
   
Cash flows from investing activities          
Acquisition of property and equipment  -0.1-0.7-0.1-0.30.0-1.1-0.2-0.4
Purchase of available-for-sale investments  -34.4-16.3-7.5-3.8-1.4-43.9  
Maturity of available-for-sale investments  13.3 9.44.00.5   
    Net cash used in investing activities  -21.2-15.01.8-15.6-1.0-34.1-0.210.5
   
Cash flows from financing activities          
Proceeds from issuance of common stock from stock option exercises  1.6 1.11.20.9 0.20.3
Income tax benefit on exercise of stock options  0.1 0.00.00.0   
Principal payments under notes payable   -8.2-5.4-2.8-1.4-4.3-1.3-1.7
    Net cash provided by (used in) financing activities  1.7 13.7-1.5-0.4 -1.362.3
   
    Net increase (decrease) in cash and cash equivalents  -13.9 15.16.45.6 -1.259.9
Cash and cash equivalents, beginning of period  102.8  74.274.2  49.9
Cash and cash equivalents, end of period  88.9 15.180.679.8 -1.2109.7
   
Supplemental cash flow information          
Cash paid for interest  0.2 1.00.30.2 0.20.5
Cash paid for income tax  1.1       
Stock-based compensation capitalized into inventories  0.0 0.00.00.0 0.00.0
   
Supplemental disclosure of noncash investing and financing activities          
Unrealized gain on available-for-sale investments  0.0   0.0   
Deferred gain (Note 4)  2.6       

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy